NIH-funded research NIH-funded research

Understanding how a protein called alpha-synuclein causes harm in Parkinson disease

Official title: Biophysical determination of the underlying cause of α-Syn oligomer toxicity

Funded at Texas A&m Agrilife Research · NIH-11171340 · Data updated 2026-11-12

This research aims to understand how changes in a protein called alpha-synuclein lead to nerve cell damage in people with Parkinson disease.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionTexas A&m Agrilife Research
NIH-funded
Lab location1 site (College Station, UNITED STATES)
Project startAugust 15, 2021
Project endJuly 31, 2027
Funding year2025
Award (this year)$283,213
NIH project number5R35GM142869-05
Project IDNIH-11171340 on NIH RePORTER

Who could benefit from this research

Could help

This foundational research is not recruiting patients, but future clinical trials stemming from this work would likely seek individuals with Parkinson disease.

Less likely to help

Patients not diagnosed with Parkinson disease or related neurodegenerative conditions would not directly benefit from this specific research.

What this research studies

Parkinson disease is linked to the clumping of a protein called alpha-synuclein inside brain cells. We believe that the way these protein clumps form, influenced by fats in brain cells, determines how toxic they are. Our team has developed a new way to look at the structure of these protein clumps without damaging them. We will use this method to see how different fat environments change the protein clumps and then test how harmful these different clumps are to brain cells from mice, helping us understand their role in Parkinson disease.

Why it matters

Potential benefit: If successful, this work could reveal new targets for treatments that prevent or slow the progression of Parkinson disease by stopping harmful protein clumps from forming.

How similar studies have gone: This project uses a novel biophysical imaging approach developed by the research group to investigate protein structures, building on existing knowledge about alpha-synuclein aggregation.

Where this research is happening

  • Texas A&m Agrilife Research
    College Station, United States
    Active

Researchers

  • Principal investigator: Kurouski, Dmitry — Texas A&m Agrilife Research
  • Study coordinator: Kurouski, Dmitry

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.